Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 13.80
+0.03 (0.22%)
Sep 5, 2025, 4:10 PM AEST
Telix Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 10.84 | 30.89 | 3.55 | -70.74 | -58.54 | -34.63 | Upgrade |
Depreciation & Amortization | 12.4 | 4.96 | 4.6 | 3.66 | 3.76 | 3.77 | Upgrade |
Asset Writedown & Restructuring Costs | -0.5 | -0.48 | 0.55 | - | - | - | Upgrade |
Stock-Based Compensation | 12.89 | 12.17 | 5.99 | 5.51 | 0.96 | 1.81 | Upgrade |
Other Operating Activities | 29.13 | 18.86 | 24.43 | 18.77 | 12.59 | 6.02 | Upgrade |
Change in Accounts Receivable | -37.42 | -35.32 | -18.67 | -13.55 | -5.23 | -0.25 | Upgrade |
Change in Inventory | -2.12 | -2 | -6.57 | -3.41 | -2.05 | -0.07 | Upgrade |
Change in Accounts Payable | 28.78 | 27.17 | 19.99 | 20.7 | 5.44 | 1.29 | Upgrade |
Change in Unearned Revenue | -6.13 | -5.79 | -3.61 | -1.91 | -1.96 | 23.72 | Upgrade |
Change in Other Net Operating Assets | -25.24 | -23.83 | -13.99 | -2.51 | 1.89 | -0.15 | Upgrade |
Operating Cash Flow | 22.63 | 26.63 | 16.28 | -43.48 | -43.14 | 1.51 | Upgrade |
Operating Cash Flow Growth | -25.62% | 63.56% | - | - | - | - | Upgrade |
Capital Expenditures | -12.99 | -8.86 | -6.6 | -4.78 | -0.97 | -0.19 | Upgrade |
Cash Acquisitions | -236.85 | -21.47 | -1.01 | -0.66 | - | -0.25 | Upgrade |
Sale (Purchase) of Intangibles | -22.33 | -12.2 | -0.76 | -4.64 | - | -0.06 | Upgrade |
Investment in Securities | -33.61 | -32.17 | -8.97 | - | - | - | Upgrade |
Other Investing Activities | -11.27 | -8.95 | -0.04 | -1.47 | -1.01 | -0.34 | Upgrade |
Investing Cash Flow | -317.04 | -83.65 | -17.37 | -11.55 | -1.98 | -0.84 | Upgrade |
Long-Term Debt Issued | - | 405.93 | 3.92 | 2.05 | - | - | Upgrade |
Long-Term Debt Repaid | - | -1.94 | -1.51 | -0.87 | -0.68 | -0.7 | Upgrade |
Net Debt Issued (Repaid) | 423.39 | 403.99 | 2.41 | 1.18 | -0.68 | -0.7 | Upgrade |
Issuance of Common Stock | 0.91 | 0.62 | 4.53 | 123.05 | 2.75 | 27.12 | Upgrade |
Other Financing Activities | -9.76 | -9.21 | - | -5.31 | - | -0.1 | Upgrade |
Financing Cash Flow | 414.54 | 395.4 | 6.94 | 118.92 | 2.07 | 26.32 | Upgrade |
Foreign Exchange Rate Adjustments | 37.23 | 24.96 | -1.14 | 0.2 | 2.4 | -1.26 | Upgrade |
Net Cash Flow | 157.35 | 363.33 | 4.71 | 64.09 | -40.65 | 25.73 | Upgrade |
Free Cash Flow | 9.64 | 17.77 | 9.68 | -48.26 | -44.11 | 1.32 | Upgrade |
Free Cash Flow Growth | -57.93% | 83.47% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 1.45% | 3.67% | 2.83% | -44.35% | -798.67% | 32.84% | Upgrade |
Free Cash Flow Per Share | 0.04 | 0.05 | 0.03 | -0.15 | -0.16 | 0.01 | Upgrade |
Cash Interest Paid | 8.55 | 2.93 | 0.54 | 0.28 | 0.14 | 0.15 | Upgrade |
Cash Income Tax Paid | 0.69 | 1.74 | 6.99 | -11.3 | -8.81 | -8.8 | Upgrade |
Levered Free Cash Flow | 13.73 | 54.01 | 42.88 | -20.88 | -27.18 | -12.76 | Upgrade |
Unlevered Free Cash Flow | 20.38 | 56.81 | 43.21 | -20.74 | -27.11 | -12.67 | Upgrade |
Change in Working Capital | -42.14 | -39.77 | -22.84 | -0.68 | -1.91 | 24.54 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.